Research programme: therapeutic drug discovery - Berg Pharma/University of Miami

Drug Profile

Research programme: therapeutic drug discovery - Berg Pharma/University of Miami

Latest Information Update: 14 Oct 2015

Price : $50

At a glance

  • Originator Berg Pharma; University of Miami
  • Class Organic chemicals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer; CNS disorders; Heart failure; Metabolic disorders

Most Recent Events

  • 13 Oct 2015 Berg and University of Miami agree to co-develop organic therapeutics in USA for Cardiac dysfunction and Heart failure
  • 09 May 2014 Early research in Heart failure in USA (unspecified route)
  • 07 May 2014 Early research in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top